March 9, 2022
SpineThera to Present at WVSIPP Incube Meeting in Conjunction with ASPN Think Tank
Medical Alley, Minnesota, united states, March 9, 2022 – SpineThera, Inc., a privately held, clinical stage pharmaceutical company focused on the development of SX600 (a novel formulation of sustained-release dexamethasone for treatment of lumbar radiculopathy) announced today that Jeff Missling, Chief Executive Officer, will be presenting at the InCube meeting hosted by the West Virginia Society of Interventional Pain Physicians (WVSIPP) in Nashville, TN on March 13, 2022. InCube is being held in conjunction with the American Society of Pain and Neuroscience (ASPN) Think Tank meeting.